Depression in Parkinson’s Disease – Profile and Assessment

1 Chaudhuri KR, Schrag A,Weintraub D Rizos A, Rodrigez-Blazquez C, Mamikonian E, et al. The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study. Mov Disord. 2020;35(1):116-33. Search in Google Scholar

2 Timmer M, Van Beek M, Bloem B, Esselink R. What a neurologist should know about depression in Parkinson’s disease. Pract Neurol. 2017; 17(5):359-68. Search in Google Scholar

3 Toloraia K, Meyer A, Bettrani S, Fuhr P, Lieb R, Gschwander U. Anxiety, depression and apathy as predictors of cognitive decline in patients with Parkinson disease. Front Neurol. 2022;13:792830. Search in Google Scholar

4 Lo Buono V, Palmeri R, De Salvo S, Berenati M, Greco A, Ciurleo R, et al. Anxiety, depression, and quality of life in Parkinson’s disease: the implications of multidisciplinary treatment. Neural Regen Res. 2021;16(3):587-90. Search in Google Scholar

5 Cummings JL. Depression and Parkinson’s disease: A review. Am J Psychiatry.1992;149(4):443-54. Search in Google Scholar

6 Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord. 2008;3(2):183-89. Search in Google Scholar

7 Van der Hoek TC, Bus BA, Matui P, Van der Marck MA, Esselink RA, Tendolkar I. Prevalence of depression in Parkinson’s disease: Effects of disease stage, motor subtype and gender. J Neurol Sci. 2011;310(1-2):220-24. Search in Google Scholar

8 Aarsland D, Påhlhagen S, Ballard C, Ehrt U, Svenningsson P. Depression in Parkinson disease-epidemiology, mechanisms and management. Nat. Rev. Neurol. 2012;8(1):35-47. Search in Google Scholar

9 Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Nonrecognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2002;8(3):193-97. Search in Google Scholar

10 Fabri M, Coelho M, Guedes L, Chendo I, Sousa C, Rosa M, et al. Response of non-motor symptoms to levodopa in late-stage Parkinson Disease: Results of levodopa challenge test. Parkinsonism Relat Disord. 2017;39:37-43. Search in Google Scholar

11 American Psychiatric Association, DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5™. 5th ed. Washington, DC: American Psychiatric Publishing, Inc.; 2013. Search in Google Scholar

12 Storkstein S, Brockman S. Management of depression in Parkinson‘s disease: a systematic review. Mov Disord Clin Pract. 2017;4(4):470-77. Search in Google Scholar

13 Williams JR, Hirsch ES, Anderson K, Bush A, Goldstein S, Grill S, et al. A comparison of nine scales to detect depression in Parkinson disease: which scale to use? Neurology. 2012;78(13):998-1006. Search in Google Scholar

14 Marsh LF, McDonald WF, Cummings J, Ravina B. Provisional diagnostic criteria for depression in Parkinson’s disease: report of an NINDS/NIMH Work Group. Mov Disord. 2006;21(2):148-58. Search in Google Scholar

15 Schrag A, Barone P, Brow R, Leentjens A, McDonald W, Starkstein S, et al. Depression Rating Scales in Parkinson’s Disease: Critique and Recommendations. Mov Disord. 2007;22(8):1077-92. Search in Google Scholar

16 Schrag A, Taddei RN. Depression and anxiety in Parkinson‘s Disease. Int Rev Neurobiol. 2017;133:623-55. Search in Google Scholar

17 Agüera-Ortiz L, Garcıa-Ramos R, Perez F, Lopez-Alvarez J, Montes Rodrıguez JM, Olazaran Rodrıguez FJ, et al. Focus on Depression in Parkinson’s Disease: A Delphi Consensus of Experts in Psychiatry, Neurology and Geriatrics. J Parkinsons Dis. 2021:6621991. Search in Google Scholar

18 Goodman J. Organic unity theory: The mind-body problem revisited. Am J Psychiatry. 1991;148(5):553-63. Search in Google Scholar

19 Prange S, Klinger H, Laurencin C, Danalia T, Thobois S. Depression in patients with Parkinson‘s Disease: Current understanding of its Neirobiology and Implications for treatment. Drugs Aging. 2022;39(6):417-39. Search in Google Scholar

20 Schrag A, Jahanshahi M, Quinn NP. What contributes to depression in Parkinson’s disease? Psychol Med. 2001;31(1):65-73. Search in Google Scholar

21 Chikatimalla R, Dasaradhan T, Koneti J, Cherukuri S, Kalluru R, Gadde S. Depression in Parkinson‘s Disease: A Narrative Review. Cereus. 2022;14(8):e27750. Search in Google Scholar

22 Arabia G, Grosssard BR, Geda YE, Carlin JM, Bower JH, Ahlskod J, et al. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. Arch Gen Psychiatry. 2007;64(12):1385-92. Search in Google Scholar

23 Kasten M, Kertelge L, Brugegemann N, Van der Vegt J, Schmidt A, Tadic V, et al. Nonmotor symptoms in genetic Parkinson disease. Arch Neurol. 2010;67(6):670-76. Search in Google Scholar

24 Belarbi S, Hecham N, Lesage S, Kedina M, Smail N, Benthasine T, et al. LRRK2 G2019S mutation in Parkinson’s disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort. Parkinsonism Relat Disord. 2010;16(10):676-79. Search in Google Scholar

25 Mayeux R, Stern Y, Cote L, Williams BW Altered serotonin metabolism in depressed patients with Parkinson’s disease. Neurology. 1984. 34: 642-46 Search in Google Scholar

26 Gerber PE, Lynd LD. Selective serotoninreuptake inhibitor induced movement disorders. Ann Pharmacother. 1998;32(6):692-98. Search in Google Scholar

27 Leentjens AF. Depression in Parkinson’s disease: conceptual issues and clinical challenges. J Geriatr Psychiatry Neurol. 2004;17(3):120-26. Search in Google Scholar

28 Paulus, W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol. 1991;50(6):743-55. Search in Google Scholar

29 Berg D, Supprian T, Hofman E, Zeiler B, Jager A, Lange KW, et al. Depression in Parkinson’s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol. 1999;246(12):1186-93. Search in Google Scholar

30 Lentijens AF, Sholtissen B, Vreeling F, Verhey F. The serotonergic hypothesis for depression in Parkinson‘s disease: an experimental approach. Neuropsychopharmacology. 2009; 31(5):1009-15. Search in Google Scholar